glp 1 and norethindrone GLP-1 receptor agonists next-generation metabolic hormone therapies in chronic kidney disease GLP-1 receptor agonists and next-generation

To report a case of non-arteritic ischemic optic neuropathy (NAION) in an otherwise healthy patient treated with Glucagon-Like Peptide-1 (GLP-1) receptor agonists (RAs) liraglutide and semaglutide

The primary drivers

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

Learn what food noise really means, why it happens, and how GLP-1 medications may help quiet constant thoughts about food, cravings, and overeating.

Protein ingredients are gaining ground as a result of GLP-1 drugs: 21 % calories, +11 % protein

Why does GLP-1 cause pancreatitis